Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
866 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC
Condition: Non-small Cell Lung Cancer
Intervention: Drug: BPI-9016M
22 Recruiting Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
Condition: Non-Small Cell Lung Carcinoma
Interventions: Drug: BGB324;   Drug: Docetaxel
23 Not yet recruiting Detection of Circulating Biomarkers of Immunogenic Cell Death
Condition: Non Small Cell Lung Cancer
Intervention: Other: Blood withdrawal
24 Not yet recruiting Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Gedatolisib;   Drug: Paclitaxel;   Drug: Carboplatin
25 Not yet recruiting Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Sevoflurane;   Drug: Propofol
26 Not yet recruiting Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Fexofenadine tablet dosing;   Drug: Osimertininb tablet dosing
27 Recruiting A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Conditions: Colorectal Cancer;   Triple Negative Breast Cancer;   Non-small Cell Lung Cancer (Adenocarcinoma)
Interventions: Biological: PDR001;   Biological: ACZ885;   Biological: CJM112;   Drug: TMT212;   Drug: EGF816
28 Not yet recruiting Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Interventions: Drug: Carboplatin;   Drug: Cediranib Maleate;   Drug: Cisplatin;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib
29 Not yet recruiting Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer
Condition: Stage I NSCLC
Intervention: Other: microwave ablation
30 Recruiting Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)
Condition: Stage IV EGFR Mutated Non-Small Cell Lung Cancer
Interventions: Radiation: Radiation: SBRT;   Drug: TKI (Gefitinib or Tarceva )
31 Not yet recruiting SIMT Stereotactic Radiosurgery Outcomes Study
Conditions: Brain Metastases;   Breast Cancer;   Non Small Cell Lung Cancer;   Gastrointestinal Cancer;   Renal Cell Cancer;   Melanoma
Intervention: Radiation: Stereotactic radiosurgery
32 Recruiting An Intensive QT/QTc Study to Investigate the Effects of Rovalpituzumab Tesirine on Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Intervention: Drug: Rovalpituzumab Tesirine
33 Recruiting Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: pembrolizumab 2 mg/kg;   Drug: Docetaxel 75 mg/m^2
34 Recruiting A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
Conditions: Advanced Cancer;   Metastatic Cancer;   Colorectal Cancer;   Non-small Cell Lung Cancer
Interventions: Drug: prexasertib;   Drug: ralimetinib
35 Not yet recruiting EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: EGFR-TKI;   Drug: Chemotherapy(pemetrexed/gemcitabine);   Drug: Chemotherapy(carboplatin)
36 Recruiting A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Conditions: Advanced Cancer;   Metastatic Melanoma;   Metastatic Non-small Cell Lung Cancer;   Metastatic Pancreatic Ductal Adenocarcinoma;   Colorectal Cancer
Interventions: Drug: LY3214996;   Drug: Midazolam;   Drug: Abemaciclib;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
37 Not yet recruiting Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
Condition: Lung Neoplasms
38 Not yet recruiting Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Carcinoma
39 Recruiting A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Injection of [18F]-ODS2004436 radiotracer
40 Recruiting Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ganoderma lucidum spore;   Drug: Placebo;   Drug: Chemotherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.